Sign In

A subscription to JoVE is required to view this content. Sign in or start your free trial.

In This Article

  • Summary
  • Abstract
  • Introduction
  • Protocol
  • Representative Results
  • Discussion
  • Acknowledgements
  • Materials
  • References
  • Reprints and Permissions

Summary

This protocol describes the procedure for genome editing in mouse bone marrow-derived macrophages using Cas9-sgRNA ribonucleoprotein complexes assembled in vitro and delivered by electroporation.

Abstract

Bone marrow-derived macrophages (BMDMs) from mice are a key tool for studying the complex biology of tissue macrophages. As primary cells, they model the physiology of macrophages in vivo more closely than immortalized macrophage cell lines and can be derived from mice already carrying defined genetic changes. However, disrupting gene function in BMDMs remains technically challenging. Here, we provide a protocol for efficient CRISPR/Cas9 genome editing in BMDMs, which allows for the introduction of small insertions and deletions (indels) that result in frameshift mutations that disrupt gene function. The protocol describes how to synthesize single-guide RNAs (sgRNA-Cas9) and form purified sgRNA-Cas9 ribonucleoprotein complexes (RNPs) that can be delivered by electroporation. It also provides an efficient method for monitoring editing efficiency using routine Sanger sequencing and a freely available online analysis program. The protocol can be performed within 1 week and does not require plasmid construction; it typically results in 85% to 95% editing efficiency.

Introduction

Macrophages are innate immune cells that play critical roles in tissue repair and immunity1,2. Immortalized macrophage cell lines, such as mouse RAW 264.7 cells or human THP-1 cells, have several beneficial characteristics, including robust growth and ease of gene disruption by delivering vectors for RNA interference or CRISPR/Cas93,4. However, oncogenic transformation dramatically alters their physiology, which results in the aberrant activation of some pathways and muted responses of others5,6

Protocol

1. sgRNA design

NOTE: This step describes selection of the target sequences and design of the sgRNAs. It is helpful to design guides that are in the first large coding exon, so that any translated protein is disrupted early in the open reading frame. It is also helpful to select target sequences that lie within the same exon, as this will streamline the analysis of the editing efficiency (step 6). The examples of genome editing provided with this protocol used sgRNAs targeting t.......

Representative Results

The IVT template is a 127 bp PCR product (Figure 1B). The full-length IVT product is a 98 nt RNA, which migrates similarly to a 70 bp double-stranded DNA fragment (Figure 1C).

After electroporation, the cells should be >90% viable, with a total cell count of >70% of the starting cell number. The resulting pool of mutant cells should have a diverse set of indels, starting near the Cas9 cleavage site. The analysis of the targete.......

Discussion

Genome editing using electroporated Cas9-sgRNA complexes allows effective disruption of gene function in BMDMs. The editing efficiency varies by the target sequence and gene. Typically, four to five sgRNAs are generally screened to identify one that is highly active. Some loci have lower editing efficiencies, most likely due the chromatin structure. In these cases, several modifications can be made to increase the editing efficiency. Co-delivery of two active sgRNAs to the same exon results in improved editing for some g.......

Acknowledgements

This work was funded by the NIH grant 5R01AI144149. The schematic figures were created with BioRender.

....

Materials

NameCompanyCatalog NumberComments
3T3-MCSF Cell LineGift from Russell Vancenot applicable
Alt-R Cas9 Electroporation EnhancerIDT1075915
Ampure XP Reagent BeadsBeckman CoulterA63880
Calf intestinal alkaline phosphataseNEBM0525S
DNaseNEBM0303S
DPBS +Ca/Mg (0.9mM CaCl2 and 0.5mM MgCl2)Thermo Fisher14040-133
DPBS -Ca/MgThermo Fisher14190-144
ExoINEBM0293S
Fetal Calf Serum (FCS)Corning35-015-CV
Herculase DNA polymerase & bufferAgilent600677
HiScribe T7 High Yield RNA Synthesis KitNEBE2040S
LoBind conical tubes 15 mLEppendorf30122216
LoBind Eppendorf tubes 2 mLEppendorf22431102
NEBuffer r2.1NEBB6002S
Neon Transfection SystemThermo FisherMPK5000, MPP100, MPS100
Neon Transfection System 10 uL TipsThermo FisherMPK1025 or MPK1096
PBS + 1mM EDTALonzaBE02017F
Proteinase KThermo FisherEO0491
rCutSmart Buffer for ExoINEBB6004S
RibolockThermo FisherEO0384
RNA loading dyeNEBB0363S
RNeasy Mini KitQiagen74104
S. pyogenes Cas9-NLSUniversity of California Macro Labnot applicableAvailable to non-UC investigators through  https://qb3.berkeley.edu
S. pyogenes Cas9-NLS, modified 3rd GenerationIDT1081059
SAPNEBM0371S

References

  1. Murray, P. J., Wynn, T. A. Protective and pathogenic functions of macrophage subsets. Nature Reviews Immunology. 11 (11), 723-737 (2011).
  2. Wynn, T. A., Chawla, A., Pollard, J. W. Macrophage biology in development, homeostasis, and disea....

Explore More Articles

Keyword Extraction Gene DisruptionPrimary Bone Marrow derived MacrophagesElectroporated Cas9 sgRNA ComplexesCRISPRGene EditingMacrophagesRNAiImmunologyGene FunctionSanger SequencingRibonucleoprotein Complexes

This article has been published

Video Coming Soon

JoVE Logo

Privacy

Terms of Use

Policies

Research

Education

ABOUT JoVE

Copyright © 2024 MyJoVE Corporation. All rights reserved